Haemonetics Corp. (HAE)
58.42
-1.11
(-1.86%)
USD |
NYSE |
Apr 09, 16:00
58.41
-0.01
(-0.02%)
After-Hours: 20:00
Haemonetics EPS Diluted (Quarterly) : 0.9522 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Edwards Lifesciences Corp. | 0.1104 |
| QuidelOrtho Corp. | -1.922 |
| Stryker Corp. | 2.197 |
| Zimmer Biomet Holdings, Inc. | 0.7032 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 44.74M |
| Revenue (Quarterly) | 338.97M |
| Total Expenses (Quarterly) | 294.23M |
| Enterprise Value | 3.576B |
| Gross Profit Margin (Quarterly) | 56.47% |
| Profit Margin (Quarterly) | 13.20% |
| Earnings Yield | 6.35% |
| Operating Earnings Yield | 8.83% |
| Normalized Earnings Yield | 6.362 |